# A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.

> **NCT06617091** · PHASE1 · RECRUITING · sponsor: **International AIDS Vaccine Initiative** · enrollment: 120 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** GRAdHIVNE1 Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06617091
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06617091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06617091, "A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06617091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*